These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18546324)

  • 1. Distribution of motor impairment influences quality of life in Parkinson's disease.
    Stewart KC; Fernandez HH; Okun MS; Jacobson CE; Hass CJ
    Mov Disord; 2008 Jul; 23(10):1466-8. PubMed ID: 18546324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationships between the unified Parkinson's disease rating scale and lower extremity functional performance in persons with early-stage Parkinson's disease.
    Song J; Fisher BE; Petzinger G; Wu A; Gordon J; Salem GJ
    Neurorehabil Neural Repair; 2009 Sep; 23(7):657-61. PubMed ID: 19336530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.
    Martignoni E; Franchignoni F; Pasetti C; Ferriero G; Picco D
    Neurol Sci; 2003 Oct; 24(3):190-1. PubMed ID: 14598081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of quality of life in multiple system atrophy and Parkinson's disease].
    Torny F; Lacoste M; Videaud H; Chouly M; Parveau MC; Couratier P
    Rev Neurol (Paris); 2009 Nov; 165(11):911-5. PubMed ID: 19324385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinically important difference on the unified Parkinson's disease rating scale.
    Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
    Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment, disability, and life satisfaction in Parkinson's disease.
    Dural A; Atay MB; Akbostanci C; Kucukdeveci A
    Disabil Rehabil; 2003 Apr; 25(7):318-23. PubMed ID: 12745955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery for Parkinson's disease improves disability but not impairment components of the UPDRS-II.
    Haffenden A; Khan U; Kiss ZH; Suchowersky O
    Parkinsonism Relat Disord; 2007 Oct; 13(7):399-405. PubMed ID: 17368072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative responsiveness of Parkinson's disease scales to change over time.
    Schrag A; Spottke A; Quinn NP; Dodel R
    Mov Disord; 2009 Apr; 24(6):813-8. PubMed ID: 19199355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
    Stebbins GT; Goetz CG
    Mov Disord; 1998 Jul; 13(4):633-6. PubMed ID: 9686766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.
    Siderowf A; McDermott M; Kieburtz K; Blindauer K; Plumb S; Shoulson I;
    Mov Disord; 2002 Jul; 17(4):758-63. PubMed ID: 12210871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients', doctors', and caregivers' assessment of disability using the UPDRS-ADL section: are these ratings interchangeable?
    Martínez-Martín P; Benito-León J; Alonso F; Catalán MJ; Pondal M; Tobías A; Zamarbide I
    Mov Disord; 2003 Sep; 18(9):985-92. PubMed ID: 14502665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What determines resilience in patients with Parkinson's disease?
    Robottom BJ; Gruber-Baldini AL; Anderson KE; Reich SG; Fishman PS; Weiner WJ; Shulman LM
    Parkinsonism Relat Disord; 2012 Feb; 18(2):174-7. PubMed ID: 21975263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the motor complications of Parkinson's disease on the quality of life.
    Chapuis S; Ouchchane L; Metz O; Gerbaud L; Durif F
    Mov Disord; 2005 Feb; 20(2):224-30. PubMed ID: 15384126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the ADL part of the unified Parkinson's disease rating scale measure ADL? An evaluation in patients after pallidotomy and thalamic deep brain stimulation.
    Hariz GM; Lindberg M; Hariz MI; Bergenheim AT
    Mov Disord; 2003 Apr; 18(4):373-81. PubMed ID: 12671942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of motor symptoms upon the quality of life of patients with Parkinson's disease.
    Gómez-Esteban JC; Zarranz JJ; Lezcano E; Tijero B; Luna A; Velasco F; Rouco I; Garamendi I
    Eur Neurol; 2007; 57(3):161-5. PubMed ID: 17213723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease.
    Rodrigues JP; Walters SE; Watson P; Stell R; Mastaglia FL
    Mov Disord; 2007 Oct; 22(13):1866-70. PubMed ID: 17659634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of disability and quality of life in mild to moderate Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B; de Haan RJ;
    Neurology; 2008 Jun; 70(23):2241-7. PubMed ID: 18519873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle regularity measured by the social rhythm metric in Parkinson's disease.
    Câmara Magalhães S; Vitorino Souza C; Rocha Dias T; Felipe Carvalhedo de Bruin P; de Bruin VM
    Chronobiol Int; 2005; 22(5):917-24. PubMed ID: 16298776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with Parkinson's disease.
    Behari M; Srivastava AK; Pandey RM
    Parkinsonism Relat Disord; 2005 Jun; 11(4):221-6. PubMed ID: 15878582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.